Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ · Manufacturing · Pharmaceutical preparations
$32.58−$0.3200 (−0.97%) on the dayAs of the close; data may be delayed.
AGIO price, last 12 months
Key stats
- Previous close
- $32.90
- Open
- $32.93
- Day range
- $32.54 – $33.33
- 52-week range
- $22.24 – $46.00
- Volume
- 996.5K
- Avg volume (20 days)
- 930.5K
- Market cap
- $1.9B
Performance
1W−1.5%
1M−4.2%
3M−14.0%
6M+8.8%
YTD+19.7%
1Y−12.7%
vs S&P 500, 1Y−29.5 pts
Technicals and fundamentals
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.9B